Literature DB >> 7507724

Expression of 25(OH) vitamin D3 24-hydroxylase gene in glial cells.

P Naveilhan1, I Neveu, C Baudet, K Y Ohyama, P Brachet, D Wion.   

Abstract

The expression of the 25(OH) vitamin D3 24-hydroxylase gene was studied in C6 glioma and rat primary glial cell culture. The expression of the 25(OH)D3 24-hydroxylase gene was not detected in C6 glioma or glial cells cultured in a serum-free medium. However, the 25(OH)D3 24-hydroxylase mRNA was induced in a dose-dependent manner in cells treated with 1,25(OH)2D3. These findings provide further evidence for an involvement of vitamin D3 metabolites in brain function.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7507724     DOI： 10.1097/00001756-199312000-00018

Source DB:  PubMed          Journal:  Neuroreport        ISSN： 0959-4965            Impact factor:   1.837


  9 in total

1.  Role of 1,25-dihydroxyvitamin D3 and extracellular calcium in the regulation of proliferation in cultured SH-SY5Y human neuroblastoma cells.

Authors:  A Celli; C Treves; P Nassi; M Stio
Journal:  Neurochem Res       Date:  1999-05       Impact factor: 3.996

2.  Vitamin D receptor and enzyme expression in dorsal root ganglia of adult female rats: modulation by ovarian hormones.

Authors:  Sarah E Tague; Peter G Smith
Journal:  J Chem Neuroanat       Date:  2010-10-20       Impact factor: 3.052

Review 3.  Crosstalk between sphingolipids and vitamin D3: potential role in the nervous system.

Authors:  Mercedes Garcia-Gil; Federica Pierucci; Ambra Vestri; Elisabetta Meacci
Journal:  Br J Pharmacol       Date:  2017-02-24       Impact factor: 8.739

4.  The transcriptomic response of mixed neuron-glial cell cultures to 1,25-dihydroxyvitamin d3 includes genes limiting the progression of neurodegenerative diseases.

Authors:  Marie-France Nissou; Jacques Brocard; Michèle El Atifi; Audrey Guttin; Annie Andrieux; François Berger; Jean-Paul Issartel; Didier Wion
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

Review 5.  Vitamin D and Alzheimer's Disease: Neurocognition to Therapeutics.

Authors:  Anindita Banerjee; Vineet Kumar Khemka; Anirban Ganguly; Debashree Roy; Upasana Ganguly; Sasanka Chakrabarti
Journal:  Int J Alzheimers Dis       Date:  2015-08-17

Review 6.  Vitamin D, Cognition and Alzheimer's Disease: The Therapeutic Benefit is in the D-Tails.

Authors:  Véréna Landel; Cédric Annweiler; Pascal Millet; Maria Morello; François Féron
Journal:  J Alzheimers Dis       Date:  2016-05-11       Impact factor: 4.472

Review 7.  Vitamin D and schizophrenia: 20 years on.

Authors:  Xiaoying Cui; John J McGrath; Thomas H J Burne; Darryl W Eyles
Journal:  Mol Psychiatry       Date:  2021-01-26       Impact factor: 13.437

8.  Genetic Variability of the Vitamin D Receptor Affects Susceptibility to Parkinson's Disease and Dopaminergic Treatment Adverse Events.

Authors:  Sara Redenšek; Tilen Kristanc; Tanja Blagus; Maja Trošt; Vita Dolžan
Journal:  Front Aging Neurosci       Date:  2022-04-19       Impact factor: 5.702

Review 9.  Vitamin D and Parkinson's Disease.

Authors:  Antonia Pignolo; Sergio Mastrilli; Chiara Davì; Valentina Arnao; Paolo Aridon; Felipe Augusto Dos Santos Mendes; Cesare Gagliardo; Marco D'Amelio
Journal:  Nutrients       Date:  2022-03-14       Impact factor: 5.717
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.